PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-21.6%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$2.63B
AUM Growth
+$2.63B
(-30%)
Cap. Flow
-$167M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
51.5%
Holding
141
New
26
Increased
20
Reduced
29
Closed
42
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$105M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$56.5M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$43.8M |
| 4 |
Allogene Therapeutics
ALLO
|
$41.6M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$30.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$65.9M |
| 2 |
CORI
Corium International, Inc.
CORI
|
$60.5M |
| 3 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$43.4M |
| 4 |
Intuitive Surgical
ISRG
|
$41.6M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$37.2M |
Sector Composition
| 1 | Healthcare | 95.05% |
| 2 | Financials | 0.08% |
| 3 | Consumer Discretionary | 0.06% |
| 4 | Industrials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EIDX
51
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $9.45M | 0.36% |
686,922
| – | – |
|
52
Akebia Therapeutics
AKBA
$827M
| $9.18M | 0.35% |
1,703,440
-746,081
| -30% | -$4.02M |
|
|
ORTX
53
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $8.21M | 0.31% |
+521,800
| New | +$8.21M |
|
54
Collegium Pharmaceutical
COLL
$1.25B
| $7.37M | 0.28% |
+445,000
| New | +$7.37M |
|
55
Zymeworks
ZYME
$1.07B
| $7.2M | 0.27% |
573,890
-550,000
| -49% | -$6.9M |
|
|
MTEM
56
DELISTED
Molecular Templates, Inc.
MTEM
| $7.11M | 0.27% |
1,974,133
| – | – |
|
57
Xencor
XNCR
$594M
| $6.83M | 0.26% |
196,810
-631,285
| -76% | -$21.9M |
|
58
Synlogic
SYBX
$17.4M
| $6.05M | 0.23% |
867,852
-75,000
| -8% | -$523K |
|
59
uniQure
QURE
$954M
| $5.95M | 0.23% |
220,707
-752,124
| -77% | -$20.3M |
|
60
TherapeuticsMD
TXMD
$12.7M
| $5.72M | 0.22% |
1,500,000
| – | – |
|
|
DBVT
61
DBV Technologies
DBVT
$249M
| $5.31M | 0.2% |
826,960
-2,183,038
| -73% | -$14M |
|
|
MRTX
62
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.25M | 0.2% |
+125,875
| New | +$5.25M |
|
|
UROV
63
DELISTED
Urovant Sciences Ltd.
UROV
| $3.92M | 0.15% |
625,359
+162,700
| +35% | +$1.02M |
|
64
Arrowhead Research
ARWR
$3.84B
| $3.58M | 0.14% |
300,000
-65,445
| -18% | -$781K |
|
65
Rocket Pharmaceuticals
RCKT
$358M
| $3.5M | 0.13% |
+240,173
| New | +$3.5M |
|
|
SRRA
66
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.41M | 0.13% |
2,666,190
-533,810
| -17% | -$683K |
|
|
TBIO
67
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $3.17M | 0.12% |
435,000
-65,000
| -13% | -$473K |
|
68
Teladoc Health
TDOC
$1.37B
| $2.97M | 0.11% |
+60,000
| New | +$2.97M |
|
69
Wave Life Sciences
WVE
$1.27B
| $2.5M | 0.1% |
59,498
-174,521
| -75% | -$7.34M |
|
70
eHealth
EHTH
$126M
| $2.11M | 0.08% |
55,021
-171,199
| -76% | -$6.57M |
|
71
Penumbra
PEN
$10.5B
| $2.04M | 0.08% |
+16,338
| New | +$2.04M |
|
72
Veru
VERU
$48.5M
| $1.85M | 0.07% |
1,425,000
| – | – |
|
|
GRCE
73
Grace Therapeutics, Inc. Common Stock
GRCE
$41.1M
| $1.48M | 0.06% |
+1,779,882
| New | +$1.48M |
|
|
EIGR
74
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.42M | 0.05% |
139,890
-17,789
| -11% | -$181K |
|
|
OMED
75
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.28M | 0.05% |
1,719,111
-901,786
| -34% | -$674K |
|